ANI Pharmaceuticals
ANIP
ANIP
146 hedge funds and large institutions have $337M invested in ANI Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 28 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
88% less call options, than puts
Call options by funds: $1.72M | Put options by funds: $14M
Holders
146
Holding in Top 10
1
Calls
$1.72M
Puts
$14M
Top Buyers
| 1 | +$6.18M | |
| 2 | +$5.85M | |
| 3 | +$5.06M | |
| 4 |
JP Morgan Chase
New York
|
+$4.85M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.49M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$5.87M | |
| 3 | -$3.74M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.68M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.95M |